Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents

BACKGROUND: The incidence of lung cancer and the cost of drug treatment have increased dramatically in the last decade. This article examines the costs of new target agents, such as tyrosine kinase inhibitors (TKIs) and anti-angiogenic drugs. METHODS: This study uses PubMed research to focus on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergnenègre, A, Borget, I, Chouaid, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626258/
https://www.ncbi.nlm.nih.gov/pubmed/23630426
http://dx.doi.org/10.2147/CEOR.S30670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626258/
https://www.ncbi.nlm.nih.gov/pubmed/23630426
http://dx.doi.org/10.2147/CEOR.S30670

Ejemplares similares